Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York 10065, USA.
Surg Infect (Larchmt). 2011 Aug;12(4):255-60. doi: 10.1089/sur.2010.073. Epub 2011 Jul 26.
Surgical site infections (SSIs) cause morbidity after elective colorectal surgery, and antibiotic prophylaxis can decrease SSIs. The aim of this study was to determine compliance with an antibiotic administration protocol, including regimen, initial dose timing, and re-dosing, and determine the risk of SSI associated with each. We hypothesized that appropriate antibiotic administration reduces the risk of SSI.
Retrospective review from a prospective database of a random sample of patients undergoing elective abdominal colorectal procedures with anastomosis. Antibiotic regimens, initial dose timing (IDT), and re-dosing were evaluated. Appropriate regimens covered gram-positive cocci, gram-negative bacilli, and anaerobes. The IDT was considered proper if completed within 30 min prior to incision; re-dosing parameters were determined pharmacokinetically for each agent. The main outcome was SSI. Sequential logistic models were generated: Model 1 assessed antibiotic administration factors, whereas Model 2 controlled for patient and clinical factors, including disease process, patient characteristics, intra-operative factors, and post-operative factors.
Six hundred five patients (mean age 59.7 [standard deviation 17.8] years, 42.8% male) were included. The most common diagnoses were cancer (38.8%) and inflammatory bowel disease (22.0%). Seventy-six patients (12.6%) had superficial or deep incisional SSI, and 54 (8.9%) had organ/space SSI. Regimens included cefazolin + metronidazole for 219 patients (36.2%), cefoxitin for 214 (35.4%), and levofloxacin + metronidazole for 48 (7.9%). One hundred fourteen patients (18.8%) received other/nonstandard regimens, and ten had no documented antibiotic prophylaxis. Fifty-five patients (9.1%) received insufficient coverage, whereas 361 patients (59.7%) had proper IDT, and 401 regimens (66.3%) were re-dosed properly. In Model 1, the use of other/nonstandard regimens (odds ratio [OR] 2.069; 95% confidence interval [CI] 1.078-1.868) and early administration of the initial prophylaxis dose (OR 1.725; 95% CI 1.147-2.596) were associated with greater odds of SSI. After adding clinical factors in Model 2, both of these factors remained significant (OR 2.505; 95% CI 1.066-5.886 and OR 1.733; 95% CI 1.017-2.954, respectively).
Appropriate antibiotic selection and timing of administration for prophylaxis are crucial to reduce the likelihood of SSI after elective colorectal surgery with intestinal anastomosis.
手术部位感染(SSI)会导致择期结直肠手术后出现发病率,抗生素预防可降低 SSI 的发生率。本研究旨在确定抗生素给药方案的依从性,包括方案、初始剂量时机和再次给药,以及确定与每种方案相关的 SSI 风险。我们假设适当的抗生素给药可降低 SSI 的风险。
对接受择期腹部结直肠手术吻合术的患者进行前瞻性数据库的回顾性随机抽样。评估了抗生素方案、初始剂量时机(IDT)和再次给药。适当的方案涵盖了阳性球菌、阴性杆菌和厌氧菌。如果在切口前 30 分钟内完成 IDT,则认为是适当的;根据每个药物的药代动力学确定再次给药参数。主要结局是 SSI。生成了序贯逻辑模型:模型 1 评估了抗生素给药因素,而模型 2 控制了患者和临床因素,包括疾病过程、患者特征、术中因素和术后因素。
共纳入 605 例患者(平均年龄 59.7[标准差 17.8]岁,42.8%为男性)。最常见的诊断是癌症(38.8%)和炎症性肠病(22.0%)。76 例(12.6%)发生浅表或深部切口 SSI,54 例(8.9%)发生器官/腔隙 SSI。方案包括头孢唑林+甲硝唑 219 例(36.2%)、头孢西丁 214 例(35.4%)和左氧氟沙星+甲硝唑 48 例(7.9%)。114 例(18.8%)患者接受了其他/非标准方案,10 例患者未记录抗生素预防。55 例(9.1%)患者接受了不足的覆盖,而 361 例(59.7%)患者接受了适当的 IDT,401 例(66.3%)方案进行了适当的再次给药。在模型 1 中,使用其他/非标准方案(比值比[OR]2.069;95%置信区间[CI]1.078-1.868)和初始预防剂量的早期给药(OR 1.725;95% CI 1.147-2.596)与 SSI 发生的几率增加相关。在模型 2 中加入临床因素后,这两个因素仍然具有统计学意义(OR 2.505;95% CI 1.066-5.886 和 OR 1.733;95% CI 1.017-2.954)。
适当的抗生素选择和预防给药时机对于降低择期结直肠手术后伴有肠吻合术的 SSI 发生率至关重要。